Dr. Darling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 Jones Bridge Rd
Uniformed Services University
Bethesda, MD 20814Phone+1 301-295-3528Fax+1 301-295-3150
Education & Training
National Institutes of Health Clinical CenterResidency, Dermatology, 1994 - 1999
Duke University HospitalResidency, Dermatology, 1991 - 1994
University of North Carolina HospitalsInternship, Internal Medicine, 1990 - 1991
Duke University School of MedicineClass of 1990
Certifications & Licensure
NC State Medical License 1993 - 2024- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 159 citationsSomatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.Kim M. Keppler-Noreuil, Victoria E. R. Parker, Thomas N. Darling, Julian A. Martinez-Agosto
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2016-12-01 - 98 citationsSafety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.Victoria E. R. Parker, Kim M. Keppler-Noreuil, Laurence Faivre, Maxime Luu, Neal L. Oden
Genetics in Medicine. 2019-05-01 - 23 citationsLymphatic Involvement in LymphangioleiomyomatosisConnie G. Glasgow, Angelo M. Taveira-DaSilva, Thomas N. Darling, Joel Moss
Annals of the New York Academy of Sciences. 2008-05-01
Journal Articles
- Safety and Efficacy of Low-Dose Sirolimus in the PIK3CA-Related Overgrowth SpectrumThomas N Darling, Brigitte C Widemann, Kristina I Rother, Nature
Press Mentions
USU Researchers Use Therapeutic Peptides to Develop Skin Substitutes for Wound HealingJanuary 18th, 2023- USU Student’s Dedication Leads to Mission Critical, Lifesaving Blood DrivesJanuary 12th, 2023
- Honoring Black Midwifery, Then and NowFebruary 23rd, 2022
- Join now to see all
Grant Support
- Regulation of Dermal Fibroblasts in Skin Regeneration and HealingNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES2012–Present
- Novel In Vitro And Xenograft Models To Study Treatments For Tuberous SclerosisNational Cancer Institute2006–2007
- Tumorigenesis In Tuberous SclerosisNational Cancer Institute2004–2007
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
